Dabrafenib Interactions
There are 507 drugs known to interact with dabrafenib, along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 86 are major, 406 are moderate, and 15 are minor.
- View all 507 medications that may interact with dabrafenib
- View dabrafenib alcohol/food interactions (1)
- View dabrafenib disease interactions (7)
Most frequently checked interactions
View interaction reports for dabrafenib and the medicines listed below.
- Activated Charcoal (charcoal)
- Advil (ibuprofen)
- Cartia XT (diltiazem)
- Centrum Silver (multivitamin with minerals)
- Centrum Silver Men's (multivitamin with minerals)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Dextrose (glucose)
- DHEA (dehydroepiandrosterone)
- Diltiazem Hydrochloride SR (diltiazem)
- Glycerol (glycerin)
- Iodides (sodium iodide)
- Iron Sulfate (ferrous sulfate)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lithium Carbonate ER (lithium)
- Mekinist (trametinib)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Multi Vitamin+ (multivitamin)
- Novolog (insulin aspart)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Valproate Sodium (valproic acid)
- Viagra (sildenafil)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Dabrafenib alcohol/food interactions
There is 1 alcohol/food interaction with dabrafenib.
Dabrafenib disease interactions
There are 7 disease interactions with dabrafenib which include:
Report options
More about dabrafenib
- dabrafenib consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Mekinist
Mekinist is used to treat melanoma, non-small cell lung cancer, thyroid cancer, solid tumors, and ...
Dacarbazine
Dacarbazine is used for hodgkin's lymphoma, melanoma, melanoma, metastatic
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
